Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras
Authors:
Open Access
- 22 August 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 5 (9) , 710-723
Abstract
Despite the success of drug discovery over the past decades, many potential drug targets still remain intractable for small molecule modulation. The development of proteolysis targeting chimeras (PROTACs) that trigger degradation of the target proteins provides a conceptually novel approach to address drug targets that remained previously elusive. Currently, the main challenge of PROTAC development is the identification of efficient, tissue- and cell-selective PROTAC molecules with good drug-likeness and favorable safety profiles. This review focuses on strategies to enhance the effectiveness and selectivity of PROTACs. We provide a comprehensive summary of recently reported PROTAC design strategies and discuss the advantages and disadvantages of these strategies. Future perspectives for PROTAC design will also be discussed.Keywords
Funding Information
- Rijksuniversiteit Groningen
- China Scholarship Council (202006220019)
This publication has 96 references indexed in Scilit:
- Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopeniaCancer Chemotherapy and Pharmacology, 2014
- Targeting the Bcl-2 family for cancer therapyExpert Opinion on Therapeutic Targets, 2012
- Bcl-xL–inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of plateletsBlood, 2011
- Mechanisms of drug resistance in kinasesExpert Opinion on Investigational Drugs, 2011
- Protein Knockdown Using Methyl Bestatin−Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding ProteinsJournal of the American Chemical Society, 2010
- Aptamers come of age – at lastNature Reviews Microbiology, 2006
- The Ubiquitin System for Protein Degradation and Some of Its Roles in the Control of the Cell‐Division Cycle (Nobel Lecture)Angewandte Chemie International Edition, 2005
- Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase ComplexMolecular and Cellular Biology, 2004
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997